France

Sanofi growth returns thanks to Dupixent and revitalised…

Oliver Brandicourt, Sanofi’s CEO has kept his promise to steer the company back on the path to growth. This change…

Brexit: A Window of Opportunity for France’s Drug Regulator?

As the UK prepares to leave the European Union in March 2019, stakeholders across the European life sciences…

Exclusive interview with David Meek, global CEO of Ipsen

Ipsen CEO David Meek provides a fascinating look into the French pharmaceutical ecosystem, Ipsen’s bold global…

Artificial IntelliFrance

France is attempting to reposition itself as a globally competitive hub for artificial intelligence R&D, with…

People to Watch in France

Vincent Leonhardt explains how the Macron administration’s zeal for life science innovation can actually place pressure on some pharma SMEs. He also discusses the challenges he faced during his first 2.5 years at the helm of Nordic Pharma in France. What are the origins of Nordic Pharma and what is the strategic significance of the French market relative to…

The Servier Way

Shedding light on the unique business model of French pharma’s most successful mid-cap. Not long ago,…

France: A World Leader in Oncology

Due to high unmet medical need, oncology is set to remain as the number one therapeutic area globally in the coming…

French Dermo-Cosmetics: More than Skin Deep

France provides a unique environment for dermo-cosmetics companies such as Pierre Fabre, Uriage, and Galderma to…

Pharma on the Move: New Trends in French Healthcare Logistics

Pharmaceuticals do not appear in pharmacies and hospitals out of nowhere, yet the logistics of transporting these…

France – The French Revolution

Last October, French authorities sent a long awaited message of support to the healthcare industry. As decision…

‘La French Tech’: France’s new entrepreneurial vibe

Growing awareness of start-up activity within France, fuelled by Minister for the Economy, Industry and Digital…